Retractable Technologies Inc (RVP) KPIs and segments
Close on Nov 17, 2026Market cap $16.92MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Retractable Technologies's business
Retractable Technologies's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Syringes($M)3 | 6.25 | 5.80 | 6.17 | 5.85 | 5.93 | 6.96 | 5.69 | 5.17 | 5.49 | 6.38 | 10.6 | 7.35 | |
United States($M) | 4.47 | 4.63 | 5.65 | 6.44 | |||||||||
North and South America (excluding U.S.)($M) | 0.57 | 0.60 | 0.15 | 0.83 | |||||||||
Other international($M) | 0.13 | 0.26 | 0.57 | 0.09 | |||||||||
EasyPoint Needles($M)3 | 0.65 | 0.99 | 2.91 | 3.85 | 4.20 | 0.98 | 3.10 | 4.86 | 0.19 | 0.70 | 3.13 | 2.57 | |
United States($M) | 4.86 | 0.04 | 0.61 | 2.57 | |||||||||
Other international($M) | 0.00 | 0.09 | 0.09 | 0.00 | |||||||||
North and South America (excluding U.S.)($M) | 0 | 0.06 | |||||||||||
Blood Collection Products($M)3 | 0.30 | 0.37 | 0.35 | 0.37 | 0.30 | 0.34 | 0.28 | 0.30 | 0.33 | 0.51 | 0.58 | 0.39 | |
United States($M) | 0.29 | 0.33 | 0.37 | 0.38 | |||||||||
Other international($M) | 0.01 | 0.00 | 0.14 | 0.01 | |||||||||
North and South America (excluding U.S.)($M) | 0 | 0 | 0.00 | ||||||||||
Other Products($M)3 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | |
United States($M) | 0.01 | 0.01 | 0.01 | 0.01 | |||||||||
Other international($M) | 0.00 | 0.01 | 0.00 | 0.00 | |||||||||
North and South America (excluding U.S.)($M) | 0 | 0.01 | 0.01 | ||||||||||
Licensing fees($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.09 | 0.10 | 0.78 | 0 | ||
Earlier reporting (last reported 2026)4 | |||||||||||||
Earlier reporting (last reported 2024)3 | |||||||||||||
11 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-14.
See a number that looks wrong?